| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.13 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.13 | 0.6 |